Trialjectory Raises $20 Million to Transform the Cancer Care Industry

PRESS RELEASE — NEW YORK, Feb. 7, 2022 /PRNewswire/ — Trialjectory (“the Company”), the AI-powered decision-support platform for patients, healthcare providers and pharma, announced today that it has raised $20 million in a Series A round led by New York-based global private equity and venture capital firm Insight Partners, with participation from new investor JAL Ventures and from existing …

Trialjectory Raises $20 Million to Transform the Cancer Care Industry Read More »